ArticleAmerican journal of physiology. Lung cellular and molecular physiology2020
Demystifying pulmonary fibrosis.
Article in American journal of physiology. Lung cellular and molecular physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Longitudinal x-ray based lung function measurement for monitoring Nintedanib treatment response in a mouse model of lung fibrosis.Scientific reports · 2023Article
- Targeting ATP12A, a Nongastric Proton Pump α Subunit, for Idiopathic Pulmonary Fibrosis Treatment.American journal of respiratory cell and molecular biology · 2023Article
- What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study.Occupational and environmental medicine · 2023Article
- CompCorona: A web application for comparative transcriptome analyses of coronaviruses reveals SARS-CoV-2-specific host response.Turkish journal of biology = Turk biyoloji dergisi · 2023Article
- From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?Translational research : the journal of laboratory and clinical medicine · 2022Review
- Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.Nature communications · 2021Article
- Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.EBioMedicine · 2021Article
- Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.bioRxiv : the preprint server for biology · 2021Article
- Age-Related Dynamics of Lung-Resident Memory CD8Frontiers in immunology · 2021Review
- The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs.Frontiers in pharmacology · 2021Review
- Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.American journal of respiratory and critical care medicine · 2020Article
- Pulmonary fibrosis: something old, something new…still waiting for a breakthrough.American journal of physiology. Lung cellular and molecular physiology · 2020Article
Corrections and comments
- Commented on by
- Commented on by
- Comment on
- Comment on
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.